November 13, 2023
A new clinical trial underway at the UC Gardner Neuroscience Institute is applying a personalized approach to pain management that doctors hope can improve post-surgical pain, reduce opioid dependence and reduce length of hospital stays.
November 15, 2023
Clinical Research News highlighted recommendations to improve recruitment in acute stroke trials, led by UC's Joseph Broderick, following the Stroke Treatment Academic Industry Roundtable XII earlier this year.
October 16, 2023
A collaborative team led by University of Cincinnati, University of North Carolina and Duke University researchers is studying how specific cancers and treatments affect patients' risk of stroke.
November 16, 2023
The University of Cincinnati Gardner Neuroscience Institute's Brandon Foreman recently published survey results identifying areas of consensus and needs for further research to develop a standard practice for comprehensively monitoring brain health in the intensive care unit.
February 2, 2023
The University of Cincinnati's Joseph Broderick, MD, commented on a recent study that found adults genetically prone to poor oral health may be more likely to also show signs of declining brain health.
January 24, 2023
MedPage Today highlighted comments from a recent editorial written by the University of Cincinnati's Eva Mistry analyzing the results of a new study that found that using clot-busting drugs in stroke patients who had recently also been given blood thinners did not raise the risk of bleeding complications.
January 3, 2023
The University of Cincinnati's Eva Mistry is leading a new study with funding support from the Patient-Centered Outcomes Research Institute that will examine the effectiveness of a stroke treatment for patients with a pre-stroke disability, one of the first studies to focus on this population.
December 8, 2022
Physics World recognized the University of Cincinnati's first-in-human trial of FLASH radiotherapy as one of the Top 10 Breakthroughs of the Year for 2022.
January 11, 2023
The University of Cincinnati's Alberto Espay, MD, spoke with NBC News about the impact of the cost of newly approved Alzheimer's drug Leqembi.
January 3, 2023
The University of Cincinnati's Caroline Billingsley, MD, was featured in a Q&A article on OncLive discussing the use of antibody-drug conjugates in ovarian cancer treatment.